Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-12

FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The U.S. FDA has approved Biogen's supplemental application for Tecfidera (dimethyl fumarate) related to its use in multiple sclerosis, reflecting an updated la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecfidera (dimethyl fumarate)

Snippet

SUPPL AP for TECFIDERA (DIMETHYL FUMARATE)